HSP90AA1 and central nervous system cancer: In contrast to higher CDK2 immunostaining in the gliomas derived from the cells transduced with scrambled control shRNA, the gliomas depleted of HSP90AA1-IT1 or upregulated with miR-885-5p displayed much lower and more variable levels of CDK2.